Free Annual Reports
Gilead and Other Big Movers on the Nasdaq on November 12, 2012
Currently, the Nasdaq has declined 0.1%, the S&P 500 is unchanged and the Dow has slipped 0.1%. The recent surge in popularity of technological stocks has launched the Nasdaq Composite Index into the spotlight, making it one of the premier indexes in the world.
The biggest movers traded on the NASDAQ so far are:
Beginner's Guide To Thinkorswim Trading Platform
Sarepta Therapeutics (Nasdaq:SRPT) rose a significant 12.4% to reach $25.58 per share. The company is currently trading a volume of 1.9 million shares.
After a big jump of 12.3%, Gilead (Nasdaq:GILD) is trading at $73 per share. So far today, the company's volume is 13.7 million shares, 2.3 times the average daily volume.
Taking a 12.3% hit, Achillion Pharmaceuticals (Nasdaq:ACHN) is currently trading at $7.91 per share. The company's volume for the day so far is 3.4 million shares. This is more trading activity than there was yesterday.
Slipping 6.8%, Ebix (Nasdaq:EBIX) is currently trading at $16.67 per share. The company's volume is currently 359,532 shares for the day, 0.3 times the average volume over the last three months.
Celgene (Nasdaq:CELG) has moved up 5.5% and is currently trading at $75.42 per share. So far today, five million shares have changed hands.
After an increase of 4%, Cyberonics (Nasdaq:CYBX) has reached a current price of $46.28. At 66,098 shares, the company's volume so far today is 0.3 times the average daily volume.
Increasing 3.7%, Synageva (Nasdaq:GEVA) is trading at $46.33 per share. The company's volume is currently 68,174 shares.
The Bottom Line No matter the economic climate, Wall Street will always have stocks that make major moves each week. It is important to weigh current activity against historical performance when making any investment decisions. Keep in mind that all these ratios should be compared against historical numbers and industry information in order to get a more complete picture.
The biggest movers traded on the NASDAQ so far are:
| Company | Market Cap | Percentage Change |
| Sarepta Therapeutics (Nasdaq:SRPT) | $579.1 million | +12.4% |
| Gilead (Nasdaq:GILD) | $49.25 billion | +12.3% |
| Achillion Pharmaceuticals (Nasdaq:ACHN) | $716.5 million | -12.3% |
| Ebix (Nasdaq:EBIX) | $681 million | -6.8% |
| Celgene (Nasdaq:CELG) | $30.24 billion | +5.5% |
| Cyberonics (Nasdaq:CYBX) | $1.23 billion | +4% |
| Synageva (Nasdaq:GEVA) | $1.09 billion | +3.7% |
Sarepta Therapeutics (Nasdaq:SRPT) rose a significant 12.4% to reach $25.58 per share. The company is currently trading a volume of 1.9 million shares.
After a big jump of 12.3%, Gilead (Nasdaq:GILD) is trading at $73 per share. So far today, the company's volume is 13.7 million shares, 2.3 times the average daily volume.
Taking a 12.3% hit, Achillion Pharmaceuticals (Nasdaq:ACHN) is currently trading at $7.91 per share. The company's volume for the day so far is 3.4 million shares. This is more trading activity than there was yesterday.
Celgene (Nasdaq:CELG) has moved up 5.5% and is currently trading at $75.42 per share. So far today, five million shares have changed hands.
After an increase of 4%, Cyberonics (Nasdaq:CYBX) has reached a current price of $46.28. At 66,098 shares, the company's volume so far today is 0.3 times the average daily volume.
Increasing 3.7%, Synageva (Nasdaq:GEVA) is trading at $46.33 per share. The company's volume is currently 68,174 shares.
The Bottom Line No matter the economic climate, Wall Street will always have stocks that make major moves each week. It is important to weigh current activity against historical performance when making any investment decisions. Keep in mind that all these ratios should be compared against historical numbers and industry information in order to get a more complete picture.
by
Investopedia Staff
Investopedia.com believes that individuals can excel at managing their financial affairs. As such, we strive to provide free educational content and tools to empower individual investors, including thousands of original and objective articles and tutorials on a wide variety of financial topics.
Free Annual Reports
